| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.67 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |